← Prism News

STAT+: What an abandoned heart failure trial says about ‘breakthrough’ devices that don’t reach patients

An abandoned heart-failure trial offers a rare window into devices that the FDA deems "breakthrough" but never reach patients.

Left 0% Center 100% Right 0% · 1 sources

All sources

Open full story with side-by-side comparison →

Prism News is a free news aggregator that breaks every story into Left, Center and Right perspectives — see what each side covers, what they ignore, and how the same event gets framed differently.